Preconference • HPV Public Health Workshop • July 3-4, 2010
Print PDF

To view the Public Health Speaker Bios please click here!

July 4, 2010 – Day 2
     

8:30 AM

  
Reflection and welcome remark
    0118_Steben_LoResMarc Steben, Institut national de santé publique du Québec, Montréal, QC, Canada

8:40 AM

  
Opening plenary - HPV: A pan-Canadian perspective
    A pan Canadian public health perspective on the challenges and opportunities for prevention and control of cervical cancer and HPV-related diseases.
106Tom Wong, Public Health Agency of Canada, Ottawa, ON, Canada
   

Research, Surveillance and Evaluation Track
    Scientific Committee [link]
    Knowledge on HPV infections has increased dramatically in the last decade and has led to the development of new prevention strategies (such as vaccines) or to adaptation of screening strategies. This session will be an occasion to share ideas and public health tools on surveillance of HPV infection and associated conditions, evaluation of related prevention strategies and research. We will also review different methodological approaches and ways to identify research priorities.
   

At the end of this track, participants will be able to:

  • Propose elements of the necessary framework for evaluation of prevention strategies, based on surveillance or other forms of data;
  • Formulate research needs.
     

9:00 AM

  
Surveillance, evaluation and research: Overview and challenges related to HPV infections and diseases
    0029_Franceschi_LoResSilvia Francheschi, International Agency for Research on Cancer, Lyon, France

9:15 AM

  
Interactive session: case studies
    Participants will move into small groups, in which they will discuss one of three scenarios. The purpose of the session will be to define the potential targets for HPV prevention surveillance and evaluation activities, to compare the different methodologies used for surveillance and evaluation and to discuss the feasibility of these methods. Finally, participants will have to select the most relevant endpoints and to identify knowledge gaps and research needs to guide public health decisions in HPV prevention.
10:30 AM  
Break
11:00 AM  
Panel
   

23Monitoring HPV prevention through registries and biobanks
Joakim Dillner, Karolinska Institutet, Stockholm, Sweden



Public health approaches to surveillance for HPV endpoints in the US: Experiences to date and new directions
Susan Hariri, Centers for Disease Control and Prevention, Atlanta, GA, USA

0133_Kliewer_LoResEvaluation of HPV 6/11 component of an HPV vaccine
Erich Kliewer, CancerCare Manitoba, Winnipeg, MB, Canada



0037_Giuliano_LoResHPV vaccination in males: disease reduction surveillance and effective evaluation
Anna Giuliano, University of South Florida, Tampa, FL, USA

 

134Using modelling and cost-effectiveness studies to inform public health decisions: what we know and what we need to find out
Karen Canfell, Cancer Council NSW, Sydney, Australia

 

Questions from the audience

Concluding remarks on Research, Surveillance and Evaluation Track
12:30 PM  
Lunch
   

Health Promotion and Education Track
    Scientific Committee [link]
    Health promotion is defined by the World Health Organization's 2005 Bangkok Charter for Health Promotion in a Globalized World as "the process of enabling people to increase control over their health and its determinants, and thereby improve their health". This track will allow participants to familiarize themselves with various HPV health promotion and education strategies. Best practices and lessons learned on planning, implementation, dissemination and evaluation of these strategies will be presented and discussed.
   

At the end of this track, participants will be able to:

  • Compare different approaches in health promotion in terms of their aims, methods and means of evaluation relevant to HPV topics;
  • Apply different strategies to promote an HPV prevention program.
     

1:45 PM

  
Basics of health promotion applied to HPV Topics
    0073_Ogilvie_LoResGina Ogilvie, BC Centre for Disease Control, Vancouver, BC, Canada
Questions from the audience

2:15 PM

  
Comparing strategies in conducting need assessments
    0135_Brabin_LoResLoretta Brabin, University of Manchester, Manchester, United Kingdom
Questions from the audience

2:45 PM

  
Steps to develop social marketing/awareness campaigns
    Vyta Senikas, Society of Obstetricians and Gynaecologists of Canada, Ottawa, ON, Canada
Questions from the audience
3:15 PM  
Break

3:45 PM

  
Interactive session: scenarios
    Moderators:
 

Eve Dubé, Institut national de santé publique du Québec, Québec, QC, Canada

141Ian Gemmill, Frontenac and Lennox & Addington Public Health, Kingston, ON, Canada

 
    Presenter:
    Ian Roe, British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada
    These sessions will look at how to disseminate new information in an effective way, as well as explore traditional and new mediums for providing information to target audiences. These sessions will use the touchpad technology (real-time polling).
5:15 PM  
Workshop closing remarks